cbdMD, Inc.
$0.75-0.27%($-0.00)
TickerSpark Score
53/100
73
Valuation
40
Profitability
60
Growth
64
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YCBD research report →
52-Week Range13% of range
Low $0.47
Current $0.75
High $2.56
Companywww.cbdmd.com
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals.
- CEO
- T. Ronan Kennedy
- IPO
- 2017
- Employees
- 42
- HQ
- Charlotte, NC, US
Price Chart
-20.00% · this period
Valuation
- Market Cap
- $7.85M
- P/E
- -0.01
- P/S
- 0.00
- P/B
- 0.84
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 57.75%
- Op Margin
- -14.20%
- Net Margin
- -15.54%
- ROE
- -11111.73%
- ROIC
- -8274.96%
Growth & Income
- Revenue
- $19.19M · -1.50%
- Net Income
- $-2,040,902 · 44.84%
- EPS
- $-1.09 · 39.11%
- Op Income
- $-2,162,590
- FCF YoY
- -154.59%
Performance & Tape
- 52W High
- $2.56
- 52W Low
- $0.47
- 50D MA
- $0.79
- 200D MA
- $0.88
- Beta
- 2.17
- Avg Volume
- 1.51M
Get TickerSpark's AI analysis on YCBD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 14, 26 | Porter Jeffrey H | other | 1,572 |
| Apr 14, 26 | Roe Kevin Charles | other | 1,572 |
| Apr 14, 26 | Swift Sibyl Nichole | other | 1,572 |
| Apr 14, 26 | Sellers Bakari T. | other | 1,572 |
| Apr 14, 26 | Stephen Scott G. | other | 1,572 |
| Apr 14, 26 | Raines William F III | other | 1,572 |
| Dec 17, 25 | Crosnoe Clark R. | sell | 461,725 |
| Dec 17, 25 | Crosnoe Clark R. | sell | 69,875 |
| Dec 17, 25 | Crosnoe Clark R. | sell | 19,101 |
| Nov 28, 25 | Kennedy Thomas Ronan | other | 445,000 |
Our YCBD Coverage
We haven't published any research on YCBD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate YCBD Report →Similar Companies
BFRI+0.10%
Biofrontera Inc.
$0.81
EVOK+0.00%
Evoke Pharma, Inc.
$11.00
SBFM-16.52%
Sunshine Biopharma, Inc.
$0.37
SNOA+5.94%
Sonoma Pharmaceuticals, Inc.
$1.07
MHUA-14.21%
Meihua International Medical Technologies Co., Ltd.
$7.61
NRSN+6.29%
NeuroSense Therapeutics Ltd.
$0.81
SSKN-21.20%
STRATA Skin Sciences, Inc.
$0.13
GBS-1.58%
GBS Inc.
$0.47